(Q44191732)

30 November 2017

title

Obesity-associated adipokines correlate with survival in epithelial ovarian cancer (English)

1 reference

30 November 2017

0 references

1 reference

Elena S Diaz

1

1 reference

30 November 2017

Beth Y Karlan

series ordinal

2

1 reference

30 November 2017

Andrew J Li

series ordinal

3

1 reference

30 November 2017

language of work or name

English

0 references

publication date

9 February 2013

1 reference

30 November 2017

1 reference

30 November 2017

volume

129

1 reference

30 November 2017

issue

2

1 reference

30 November 2017

page(s)

353-357

1 reference

30 November 2017

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Epidemiology of ovarian cancer: a status report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Does smoking increase risk of ovarian cancer? A systematic review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Alcohol drinking and epithelial ovarian cancer risk. a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Effect of obesity on survival in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Serum low-density lipoprotein levels correlate with survival in advanced stage epithelial ovarian cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Impact of beta blockers on epithelial ovarian cancer survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Effect of obesity on survival of women with epithelial ovarian cancer: a systematic review and meta-analysis of observational studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Obesity and ovarian cancer survival: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Carboplatin dosing in obese women with ovarian cancer: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Obesity and cancer: the role of dysfunctional adipose tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Leptin is a growth factor in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Adiponectin and cancer: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

The role of adiponectin in cancer: a review of current evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Targeting the adiponectin:leptin ratio for postmenopausal breast cancer prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Serum adiponectin and leptin levels in Taiwanese breast cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Activation of downstream signals by the long form of the leptin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Correlation between expression of leptin and clinicopathological features and prognosis in patients with gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Increased serum leptin levels and over expression of leptin receptors are associated with the invasion and progression of renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Prostate cancer and adiponectin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Differential effects of leptin on cancer in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Adiponectin as a growth inhibitor in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Balance of adiponectin and leptin modulates breast cancer cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Role of the adiponectin leptin ratio in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Expression of leptin receptors and potential effects of leptin on the cell growth and activation of mitogen-activated protein kinases in ovarian cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

The balance between leptin and adiponectin in the control of carcinogenesis - focus on mammary tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Adiponectin haploinsufficiency promotes mammary tumor development in MMTV-PyVT mice by modulation of phosphatase and tensin homolog activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Effects of chronic vs. intermittent calorie restriction on mammary tumor incidence and serum adiponectin and leptin levels in MMTV-TGF-α mice at different ages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Effect of chronic and intermittent calorie restriction on serum adiponectin and leptin and mammary tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Insulin-like growth factors and neoplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Interleukin-6 as a therapeutic target in human ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Paraneoplastic thrombocytosis in ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Hormone response in ovarian cancer: time to reconsider as a clinical target?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Understanding obesity and endometrial cancer risk: opportunities for prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Oestrogen receptor α mediates 17β-estradiol enhancement of ovarian cancer cell motility through up-regulation of survivin expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

Metformin intake is associated with better survival in ovarian cancer: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.006

10.1016/J.YGYNO.2013.02.006

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference